479 related articles for article (PubMed ID: 25983292)
1. [The role of the PD-1 protein in pathogenesis of autoimmune diseases, with particular consideration of rheumatoid arthritis and systemic lupus erythematosus].
Siwiec A; Majdan M
Postepy Hig Med Dosw (Online); 2015 Apr; 69():534-42. PubMed ID: 25983292
[TBL] [Abstract][Full Text] [Related]
2. [Active forms of oxygen and pathogenesis of rheumatoid arthritis and systemic lupus erythematosus].
Lisitsyna TA; Ivanova MM; Durnev AD
Vestn Ross Akad Med Nauk; 1996; (12):15-20. PubMed ID: 9102073
[TBL] [Abstract][Full Text] [Related]
3. Mucosal-associated invariant T cell deficiency in systemic lupus erythematosus.
Cho YN; Kee SJ; Kim TJ; Jin HM; Kim MJ; Jung HJ; Park KJ; Lee SJ; Lee SS; Kwon YS; Kee HJ; Kim N; Park YW
J Immunol; 2014 Oct; 193(8):3891-901. PubMed ID: 25225673
[TBL] [Abstract][Full Text] [Related]
4. Selfie: Autoimmunity, boon or bane.
Ahsan H
J Immunoassay Immunochem; 2017; 38(3):235-246. PubMed ID: 28421864
[TBL] [Abstract][Full Text] [Related]
5. Mutual activation of CD4+ T cells and monocytes mediated by NKG2D-MIC interaction requires IFN-gamma production in systemic lupus erythematosus.
Yang D; Wang H; Ni B; He Y; Li J; Tang Y; Fu X; Wang Q; Xu G; Li K; Yang Z; Wu Y
Mol Immunol; 2009 Apr; 46(7):1432-42. PubMed ID: 19200602
[TBL] [Abstract][Full Text] [Related]
6. The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis.
Liao W; Zheng H; Wu S; Zhang Y; Wang W; Zhang Z; Zhou C; Wu H; Min J
Am J Nephrol; 2017; 46(5):371-379. PubMed ID: 29069649
[TBL] [Abstract][Full Text] [Related]
7. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
[TBL] [Abstract][Full Text] [Related]
8. Salt Behind the Scenes of Systemic Lupus Erythematosus and Rheumatoid Arthritis.
Afsar B; Afsar RE
Curr Nutr Rep; 2023 Dec; 12(4):830-844. PubMed ID: 37980312
[TBL] [Abstract][Full Text] [Related]
9. Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus.
Lin SC; Yen JH; Tsai JJ; Tsai WC; Ou TT; Liu HW; Chen CJ
Arthritis Rheum; 2004 Mar; 50(3):770-5. PubMed ID: 15022318
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum autoantibodies against co-inhibitory PD-1 facilitate T cell proliferation and correlate with disease activity in new-onset systemic lupus erythematosus patients.
Shi H; Ye J; Teng J; Yin Y; Hu Q; Wu X; Liu H; Cheng X; Su Y; Liu M; Gu J; Lu T; Chen H; Zheng H; Sun Y; Yang C
Arthritis Res Ther; 2017 Mar; 19(1):52. PubMed ID: 28274252
[TBL] [Abstract][Full Text] [Related]
11. Association between PDCD1 Gene Polymorphisms and Risk of Systemic Lupus Erythematosus in Three Main Ethnic Groups of the Malaysian Population.
Chua KH; Lian LH; Sim XJ; Cheah TE; Lau TP
Int J Mol Sci; 2015 Apr; 16(5):9794-803. PubMed ID: 25938972
[TBL] [Abstract][Full Text] [Related]
12. PDCD1 single nucleotide genes polymorphisms confer susceptibility to juvenile-onset systemic lupus erythematosus.
Mahmoudi M; Rezaiemanesh A; Salmaninejad A; Harsini S; Poursani S; Bahrami T; Tahghighi F; Ziaee V; Rezaei N
Autoimmunity; 2015; 48(7):488-93. PubMed ID: 26108738
[TBL] [Abstract][Full Text] [Related]
13. Proinflammatory Differentiation of Macrophages Through Microparticles That Form Immune Complexes Leads to T- and B-Cell Activation in Systemic Autoimmune Diseases.
Burbano C; Villar-Vesga J; Vásquez G; Muñoz-Vahos C; Rojas M; Castaño D
Front Immunol; 2019; 10():2058. PubMed ID: 31555283
[TBL] [Abstract][Full Text] [Related]
14. Associations between Polymorphisms in the IL-1 Gene and the Risk of Rheumatoid Arthritis and Systemic Lupus Erythematosus: Evidence from a Meta-Analysis.
Zhu L; Chen P; Sun X; Zhang S
Int Arch Allergy Immunol; 2021; 182(3):234-242. PubMed ID: 33285551
[TBL] [Abstract][Full Text] [Related]
15. The PD-1/PD-Ls pathway and autoimmune diseases.
Dai S; Jia R; Zhang X; Fang Q; Huang L
Cell Immunol; 2014 Jul; 290(1):72-9. PubMed ID: 24908630
[TBL] [Abstract][Full Text] [Related]
16. Rheumatoid arthritis: Recent advances on its etiology, role of cytokines and pharmacotherapy.
Alam J; Jantan I; Bukhari SNA
Biomed Pharmacother; 2017 Aug; 92():615-633. PubMed ID: 28582758
[TBL] [Abstract][Full Text] [Related]
17. Increased CCR4 expression on circulating CD4(+) T cells in ankylosing spondylitis, rheumatoid arthritis and systemic lupus erythematosus.
Yang PT; Kasai H; Zhao LJ; Xiao WG; Tanabe F; Ito M
Clin Exp Immunol; 2004 Nov; 138(2):342-7. PubMed ID: 15498047
[TBL] [Abstract][Full Text] [Related]
18. Costimulatory molecule CD154 in systemic lupus erythematosus and rheumatoid arthritis. Therapeutic perspectives.
Dejica DI; Manea EM
Roum Arch Microbiol Immunol; 2006; 65(1-2):66-74. PubMed ID: 17877113
[TBL] [Abstract][Full Text] [Related]
19. Biosemantics guided gene expression profiling of Sjögren's syndrome: a comparative analysis with systemic lupus erythematosus and rheumatoid arthritis.
Shah NR; Noll BD; Stevens CB; Brennan MT; Mougeot FB; Mougeot JC
Arthritis Res Ther; 2017 Aug; 19(1):192. PubMed ID: 28818099
[TBL] [Abstract][Full Text] [Related]
20. A redundant epistatic interaction between IRF5 and STAT4 of the type I interferon pathway in susceptibility to lupus and rheumatoid arthritis.
Kim K; Cho SK; Han TU; Kim JH; Kang SJ; Kang C; Bae SC
Lupus; 2013 Nov; 22(13):1336-40. PubMed ID: 24014567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
